Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04700735 · ClinicalTrials.gov registry record
Cross Therapy Registry - Edema - US
A clinical trial, sponsored by Firstkind.
- Completed
- Registry status
- 83
- Enrollment target
NCT04700735 is a clinical trial that has completed, run by Firstkind. The registered enrollment target is 83 participants.
The verdict
NCT04700735 has completed, sponsored by Firstkind.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The geko™ Cross Therapy Registry - Edema (gekoTM CTR - Edema) study will prospectively and systematically collect clinical data on all device variants used in standard care pathways for edema management allowing for the monitoring of patient outcomes during a follow-up period of up to twelve months.
Interventions
- DEVICE geko Neuromuscular Electro Stimulator (NMES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2023-11-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04700735
The ClinicalTrials.gov registry entry for NCT04700735 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Firstkind, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which geko Neuromuscular Electro Stimulator (NMES) is the first listed.
NCT04700735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04700735 about?
NCT04700735 is a clinical study titled "Cross Therapy Registry - Edema - US". The geko™ Cross Therapy Registry - Edema (gekoTM CTR - Edema) study will prospectively and systematically collect clinical data on all device variants used in standard care pathways for edema management allowing for the monitoring of patient outcomes during a follow-up period of up to twelve months.
What is the current status of trial NCT04700735?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2021-06-22. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT04700735?
The interventions under investigation include: geko Neuromuscular Electro Stimulator (NMES) (DEVICE).
Who is sponsoring clinical trial NCT04700735?
This trial is sponsored by Firstkind, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.